Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection.

Abstract

BACKGROUND One-week low-dose proton pump inhibitor-based triple therapies have usually proved to be effective treatments for Helicobacter pylori infection. AIM To investigate the eradication efficacy, safety profile and patient compliance of two triple therapies containing a standard dose of rabeprazole and a new fluoroquinolone, levofloxacin. METHODS… (More)

Topics

Cite this paper

@article{Cammarota2000EfficacyOT, title={Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection.}, author={G. Cammarota and Roberta Cianci and Oreste Cannizzaro and Louis Cuoco and Giuseppe Antonio Pirozzi and A Gasbarrini and Alessandro Armuzzi and Maria Assonta Zocco and Lory Santarelli and Fabiola Arancio and Giovanni Battista Gasbarrini}, journal={Alimentary pharmacology & therapeutics}, year={2000}, volume={14 10}, pages={1339-43} }